Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-04-07 00:00:00 ET · period of report 2025-04-03 · accession 0001510281-25-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-04-07 | 2025-04-03+ | HQL | Weinstein Boaz | 10% | S - Sale | $11.97 | -17.2K | 3.12M | -0.5% | -$205.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-03 | S | D | 10,321 | $12.23 | 3,131,361 | I - | — | — | |
| 2 | Common | Common Stock | 2025-04-04 | S | D | 6,889 | $11.57 | 3,124,472 | I - | — | — |